RF Surgical raises $12 million in financing
The company intends to use the new capital to support the expansion of its RF Surgical Detection System into acute care hospitals throughout the country. The company has
AstraZeneca and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have signed an exclusive licence agreement for TQC3721.